|
Market Closed -
Japan Exchange
07:30:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 5,666.00 JPY | +0.16% |
|
-1.51% | +17.19% |
| 09-09 | Takeda Publishes Phase 3 Data Demonstrating Oveporexton Improves Narcolepsy Type 1 Symptoms | CI |
| 09-08 | Pharvaris' genetic disorder drug meets main goal in late-stage trial | RE |
Chart: Technical Analysis
Japan ExchangeJPY
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4502 | Delayed | |
OTC Markets
| TKPHF | Delayed | |
Tradegate
| TKD | Real-time | |
Deutsche Boerse AG
| TKD | Delayed | |
Börse Stuttgart
| TKD | Delayed | |
Boerse Muenchen
| TKD | Real-time | |
Wiener Boerse
| TKD | End-of-day quote | |
NYSE
| TAK | Delayed | |
CBOE
| TAK | Real-time | |
London S.E.
| 0A87 | Delayed | |
Deutsche Boerse AG
| TKDA | Delayed | |
Börse Stuttgart
| TKDA | Delayed | |
Tradegate
| TKDA | Real-time | |
Boerse Muenchen
| TKDA | Real-time | |
Sao Paulo
| TAKP34 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 5,908 | 5,908 | 5,840 |
| Spread/Res. | -4.10% | -4.10% | -2.98% |
| Spread/Supp. | +2.70% | +7.53% | +36.43% |
| Support | 5,517 | 5,269 | 4,153 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4502 Stock
- Charts Takeda Pharmaceutical Company Limited
Select your edition
All financial news and data tailored to specific country editions

















